chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The adverse event was reported to me  (I am a Clinical Consult Pharmacist) during a conversation with the the patient's doctor's office. I spoke with RN from the doctor's office concerning a clinical clarification for an asthma medication they prescribe, and at that time the nurse reported that the patient  has experienced worsening breathing, neuropathy and skin changes after receiving the COVID vaccine in March of 2021.The doctor was increasing the patient's frequency of her medication due to these worsening symptoms.  The doctor's office also stated they are not recommending COVID booster for this patient. The pharmacy location mentioned and manufacturer of Moderna COVID vaccine have been obtained through the patient's insurance claim history visible at my site. I have not confirmed the vaccination location or manufacturer with this pharmacy and the doctor's office had not specified which vaccine was given prior to me finding the insurance claim.
Patient came in to for a scheduled COVID19 Vaccine, and was given one, first dose  (0.3ml) of the Pfizer/BioNTech vaccine.. Unbeknownst to the immunizing staff patient was apart of a clinical trial for the Astra Zeneca Vaccine and did not disclose this information at the time prior, during, or after administration. Immunizing staff remained unaware until staff was contacted by Health and Human Services. Pharmacy has since tried to contact patient for interview to inquire about any adverse reactions, patient unavailable for interview.
Tingling throat - Benadryl IM 50mg per protocol, patient reported tingling went away in 20 minutes after Benadryl injection
Fever/fluctuating; Chills; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever/fluctuating) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No past medical history was reported.     On 07-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever/fluctuating) and CHILLS (Chills). At the time of the report, PYREXIA (Fever/fluctuating) and CHILLS (Chills) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Mar-2021, Body temperature: 101 (Inconclusive) 101.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported. Concomitant product use was not provided by the reporter.
Client had Moderna vaccines for Covid on Jan 20 and Feb 20 2021.  Developed symptoms of Covid 11/18 - nasal congestion, cough, headache.  PCR + for Covid 11/22.
Patient received Moderna and Pfizer vaccine3; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTRATION ERROR (Patient received Moderna and Pfizer vaccine3) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2020, the patient experienced PRODUCT ADMINISTRATION ERROR (Patient received Moderna and Pfizer vaccine3). At the time of the report, PRODUCT ADMINISTRATION ERROR (Patient received Moderna and Pfizer vaccine3) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No  concomitant medication provided by the reporter. no treatment information provided by the reporter
This case was reported by a other health professional via call center representative and described the occurrence of therapy non-responder in a female patient who received Hepatitis B vaccine for prophylaxis. On an unknown date, the patient received Hepatitis B vaccine at an unknown dose. On an unknown date, unknown after receiving Hepatitis B vaccine, the patient experienced therapy non-responder. On an unknown date, the outcome of the therapy non-responder was unknown. It was unknown if the reporter considered the therapy non-responder to be related to Hepatitis B vaccine. Additional details were provided as follows: The age at vaccination was not reported. The healthcare professional reported that after a primary hepatitis B series the patient did not seroconvert. The patient was transferred to the reporter's practice so they did not know what vaccine was given as the primary series, but she was going to look into it so might have more information later. Lab Comments: On an unknown date, the patient underwent serology test (for Hepatitis B antibody).
Chills at 8 pm  on 9/22/2023 lasting 24 hours Fever at 10 pm on 9/22/2023 lasting 12 hours took ibuprofen  4 times Nausea at 8 pm on 9/22/2023 lasting 48 hours Vomiting at 11pm on 9/22/2023 lasting 2 hours Anorexia at 8pm on 9/22/2023 ending 9/26/2023 Fatigue at 8pm on 9/22/2023 ending 9/26/2023 Headache at 8 pm on 9/22/2023 ending 9/25/2023 Pain at injection site L arm at 11 pm on 9/22/2023 ended 9/26/2023 Pain at injection site R arm at 11 pm on 9/22/2023 ended 9/26/2023 Itching at injection site R arm on 9/23/2023 ended 9/26/2023
Patient said extremely swollen and red arm. Never followed up with the pharmacy and didnt say how long after the shot. She was still in viscinity of pharmacy for 10 minutes after the immunization and did not mention any reaction to pharmacy.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 6-decade-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Batch/Lot Number: Unknown, Expiration date: Unknown) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient had a sore arm for 1 day post vaccination. The clinical outcome of the event was unknown.  Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Headache - substantial, lasted from night of vaccine through following day.  Mostly gone after 2 days. Fever (100+) - started afternoon after the day of vaccine (approx. 24 hours), intermittent throughout next 2 days.  Moderated with Acetaminophen. General tiredness, low energy.
I am emailing you about filing a petition for the Moderna COVID-19 vaccination that I received on Wednesday February 17, 2021, at the Department. I went to my primary care providers for my annual physical and to address my concerns with the vaccination. I gave blood work. Later into my afternoon, I notice that I began to itch across my sternum and I thought it was an allergic reaction to some of my common allergies. I took some Benadryl to calm the itching to get rest. I was out of work from Wednesday February 17, 2021, @ 1300 to Friday February 19, 2021, without pay, returning on Monday February 22, 2021.   On Monday February 22, 2021, I came into work and felt fatigue, light headed, headache, blurred vision, and some great deal of body pain. Approximately 2145, I notice that I was having trouble breathing and began itching profusely. I grabbed my epi pen and gave myself an injection. I laid back on the bed and I fell asleep. The following day Tuesday February 23, 2021, I barely had energy to get up and get ready for work. I prevailed because there is nothing set in place for people who experience an delayed allergic reaction to these vaccinations. I have literally been pushing myself through my workdays because I can not afford to be off.   On Sunday February 28, 2021, I notice that the rash began to spread across my body parts. My arms, neck, shoulder, upper back, behind my ears, legs, and again I figured it related to my allergies. The condition continued to get worst throughout the next week. It was several occasions I almost lost control of my vehicle because the itching sensation had hit me instantly while driving. Once I was able to pull over, I just began to scratch every area of my body. Therefore, Friday March 5, 2021, I drove myself to Hospital too seek help.   I explained my situation, I was checked in, and I showed how the rash had spread all over my body. It was nothing they could do but give me IV fluid, did some blood work and Prednisone 10mg (5 tablets) and send me home without relief. I continue to suffer from this vaccination and no one has any answers to give me. My scar-less skin now looks unattractive and dark spots where there was a rash that came and went but left awareness that I once had a rash in that spot.   I am scheduled to see my dermatologist today, Thursday, March 11, 2021. My appointment time is 1615. I went my employer to file a notice of the outbreak and to see what if anything that they could do. It was just a standard report and they are submitting all information to the CDC.   I am a health care professional and my job requires me to stand, sit, bend, lift, push, pull and assist in all aspects of an operating room that has caused me some issues and concerns that I can not perform my duties as required due to the severely of the itching.
Redness & swelling.  Redness was 5 cm across. Swelling was slight more like a knot under the skin; started the morning after the shot & continued to grow.
p/vax pt devel pain on lt pointer finger, pain went to lt wrist, pain migrates to rt pointer finger then migrated to rt wrist, very painful;pain went to rt shoulder, pain migrated to both knees;pt feels lethargic;comes & goes;
tinnitus/ it was worsening and has continued; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date in 2021 (Batch/Lot number was not reported) as dose 3 (booster), single for COVID-19 immunisation. Medical history included tinnitus from Feb2021 and ongoing. The patient's concomitant medications were not reported. The patient received the first dose of BNT162B2 on 14Jan2021 and the second dose on 04Feb2021 for COVID-19 immunization and experienced Tinnitus. The patient called and reported a personal side effect from the COVID vaccine. He stated he got his first dose on 14Jan2021 and second dose on 04Feb2021, 3 weeks later. He stated that he had the onset of tinnitus and could not recall the exact date in there, all he can recall was it was the beginning of Feb2021 and could not recall if it was after the first or 2nd dose. He relayed that it lingered and now he got the booster last Thursday, 7 days ago (unspecified date in 2021) and the tinnitus became worse. He stated that he noticed last Friday that it was worsening and has continued. He has been researching and has seen a small number reporting but like over 10, 000 but based on how many have received the vaccine, it is not more than 1%. He stated that he is concerned for himself and for others. The outcome of the event was not recovered.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
10/12/12 5 1/2 x 4 1/2 (R) red, swollen 4 x 2 1/2 (L) red, swollen, bruised.
1/21 vaccinated-11 days after rash present, now traveling down towards elbow
Angioedema of the face occurred evening of 4/19, 7 days after 4th Moderna Covid booster. Swelling,redness of face with itching,peeling skin, no shortness of breath of throat involvement.
My son fainted and began to seizure for 5-10 seconds immediately following the injection. He came to and was given a popsicle and some cold water. Watched for 15 minutes and then released.
This case was reported by a nurse and described the occurrence of injection site redness in a 4 year old female patient who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. In June 2003, the patient received the fifth dose of Infanrix. Subsequently, the patient developed a golf ball size red area on the upper arm. The patient was seen by the physician. The outcome of the event is unknown. Comment: The reporter indicated that three additional patients experienced more redness than normal following receipt of Infanrix lot DTPA590A9 for the fifth dose in the immunization series. However, these subjects are not presently identifiable.
On December 18, 2021, Community Health Center held a vaccine event as part of efforts to provide COVID-19 vaccinations to the local community.  During the event, 2 vials of the 14-dose Moderna COVID-19 vaccine was brought to the event. After the event, review of our records showed that 53 individuals were provided vaccine doses - majority of the doses that were given were booster doses. Internal review determined that staff working during the vaccine event were knowledgeable and aware that each vial of the vaccine may only be punctured up to 20 times, therefore for the 2 14-full dose vials, the maximum should be 40 doses. Because 13 extra doses were given, our staff contacted the Moderna hotline, and Moderna recommended reporting to VAERS. There was no note by staff of degradation of the vial stoppers of the two Moderna COVID-19 vaccine vials during the event. There was also no note of adverse events reported by vaccinees from the said event.  Because of this incident, health center has put in place protocols for better monitoring of equipment and supplies for vaccination and vaccine events and proper communication between staff and better recording.
Client received Moderna Bivalent on 6/30/23 at Health Department location. On 7/2/23, per client's parents' statement, client's parents found out that the client was having itchy rash and red spots all over the body. Client was brought to and treated at Emergency Center.  The client was treated with Prednisolone and Wal-Dryl Allergy relief. After about two days, the rash appeared better and no signs of rash noted as of today.
Headache, Myalgia, FATIGUE, SHOULDER AND SORE ARM Narrative:
Vaccine given in right arm, Arm swelled up, got very hot. Severe pain in arm, shoulder, and, neck. Got red blotches 3-4 inches in diameter on arm, shoulder, and neck. Fever of 102.7 or 102.9 for 3 days. Headache, nausea, and vomiting.
69 expired doses administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012H21B) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (69 expired doses administered). On 07-Jan-2022, EXPIRED PRODUCT ADMINISTERED (69 expired doses administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2022-449479 (Patient Link).
This spontaneous report was received from a nurse who is also an office manager, via company representative, regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, or concomitant therapies were not reported. On an unknown date, the patient was vaccinated with an expired dose of PNEUMOVAX23 (strength, dose, route, lot number and expiration date were not reported) for prophylaxis. No adverse effected were reported. Additional information has been requested.
Patient reports feeling dizzy and slight nausea.  patient took Tylenol after vaccine due to left arm pain. denies shortness of breath, dyspnea, hives or itchiness. patiant has history of diabetisl  type II , seasonal allergies  and anxiety. she stated  that never has reactions to vaccines in the past. patient instructed to lie down flat and stay hydrated.  educated that warm tea and toast will help with the nausea. felt better after laying flat. instructed to finish 15 minutes  observation time and to notify if symptoms get worse.
On 3/24/21 pt. Came to ED with bloody nose. Upon routine lab draw, platelet count was zero. Please follow up with PCP for further diagnoses and treatment plan.
Patient called office to report after receiving her Flu Vaccine (FLUBLOK) Left Deltoid at our Flu clinic on 9/14/2018 at 6:30am from our RN, she went home and went to sleep after working night shift. When she awoke she states she had an all over body rash of hives, that was very itchy. She reported yesterday Monday 9/17/2018 she did not seek treatment and does not wish to seek treatment for the rash at this time, the rash was resolving. She did state she wants to report this reaction. Patient stated she has had the flu vaccine every year and never had a problem or reaction before. She does not believe she has had the FLUBLOK prior to this dose. Patient states she has no known allergies and is generally healthy.
Pneumonia; Eosinophil count high; allergic reaction; This is a spontaneous report from a contactable consumer (patient's wife). An 81-year-old male patient received the first dose of COVID-19 vaccine (UNSPECIFIED TRADE NAME), via an unspecified route of administration on 04Jan2021 at single dose for covid-19 vaccination. The patient's medical history and concomitant medications were not reported. The patient had his first vaccine dose on 04Jan, then 7 days later he was in the hospital with a really high eosinophils count and infiltrate in his lungs, they did a CAT scan, and he had pneumonia in there. Patient's wife said that he was in the hospital for three days for Pneumonia, and now he was out of the hospital and he was supposed to get his second dose of the vaccine on the 25th. She would like to know if her husband should have the second dose, since she didn't know if the pneumonia was caused from the vaccine for sure, it could be an allergic reaction for the vaccine since his count was 22.2 for absolute eosinophils and that was down now to 2.4. She would like to know if it was safe for him get the second dose. She said her husband was still coughing and she didn't know, she was afraid for him to get it. The patient underwent lab tests and procedures which included a CAT scan in Jan2021 and he had pneumonia in there , absolute eosinophils: 22.2 (Eosinophil count high) in Jan2021, absolute eosinophils: 2.4 in Jan2021. The outcome of the events was unknown.  Information about lot/batch number has been requested.
PATIENTS ARM BECOME VERY SORE, HOT TO THE TOUCH AND RED FROM THE SHOULDER DOWN TO THE ELBOW.
Patient was given vaccine, later that evening patient became sick. Symptoms Include shaking, vomiting, irritable, continued for several days. Patient Lipids was if centered on bladder and bowel 4dys later. Seen in clinic. given injection of Phenergan and cortisone.
Booster dose of COVID19 vaccine was given to someone under 18 yrs old, this is not a valid dose due to age.
About 15 minutes after vaccination, patient began to experience acute pyrexia and nausea.  No vomiting.  No syncope.  Vital signs within normal limits.  Borderline tachy.  No hypertension, but some shortness of breath and some lightheadedness..  After 1st vaccination , developed body aches and wrist burning on 2nd day.  Taken to ED where BP 129/77, HR 80, O2 sat 97%.  EKG showed NSR.  Symptoms resolved on own.
This spontaneous report has received from a Medical Assistant referring to a patient of unknown age and unknown gender. Information about concurrent condition, concomitant medication and medical history was not provided. On 14-JUN-2016, the patient received an expired dose PNEUMOVAX 23 (lot # K019561, expiration date 20-APR-2016, dose and frequency were unknown) intramuscularly. No known adverse effects were reported. Additional information has been requested.
Headache, Rash, blotchy rash Narrative:    Other Relevant History:
On 10/16/2000 the patient experienced abdominal pain, joint pain, low back pain, headache, and blisters erupting. A rash started to appear sporadically, "a little bit all over" and there was burning at the injection site. The eruptions "scabbed over in 2 weeks" but the patient still had some pain and a headache. Unspecified medical attention was sought. Additional information has been requested. Per F/U 6/17/02: On 10/20/00, previously reported as 10/16/00, the pt experienced his symptoms as above. There were no lab tests done. Unspecified medical attention was sought. Outcome status was no reported. F/U info indicated that the pt also had left arm pain starting on 10/20/00. The pt recovered on 11/28/00. No further info is expected.
Commenced with a metallic taste in mouth, congestion in the back of the throat and tingling around lips/mouth. 25mg Benadryl followed by 25mg within 30 minutes to control allergic symptoms. Onset of severe chills followed almost immediately, lasting about 45 minutes. Fever of 101.  Naproxen given. Fever reduced.  Body aches, lost of appetite, headache and fatigue.
Friday got vaccines night time showed no high fever she woke up next day saying arms hurt gave her some medicine (ibuprofen) she ate was getting ready to take her a bath after 5 mins of being in the bath I turn around and she fell I pick her up n notice shes shaking she's had a fever seizure before so I called 911 they came we went to hospital they ran test on her ended up discharging her even tho she was still unconscious they prescribed her some medicine and told me to give her fluids. We came home after about 2 hrs of being up she still wasn't awake much she couldn't even keep her eyes open long enough to drink water or take medicine. Called the hospital it was around 8pm the same day they discahrged her n they told me to bring her back in. We went back to the hospital as soon as we got there they tried to wake her up started trying to put an iv in her something they didn't do first time we went to hospital. They decided they wanted to run a cat scan & x-ray on her and a spinal tap. So we gave them permission. They did those then came back n ask if they can do urine test after I told them they did one earlier they said they would have to do another. Later they came back said her test came back good but she's was gonna have to b admitted. So we end up staying over night while they watch her
Deep cough with wheezing; violent coughing; fever; poss pneumonia; wheezing; difficulty breathing, hoarseness. I required antibiotics prescribed by my PCP (5-day course for Pertussis)
sweating; fever started at 11pm and through the night; Little Headache; arm hurt; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Little Headache), VACCINATION SITE PAIN (arm hurt), HYPERHIDROSIS (sweating) and PYREXIA (fever started at 11pm and through the night) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HEADACHE (Little Headache) and VACCINATION SITE PAIN (arm hurt). On 27-Apr-2021, the patient experienced PYREXIA (fever started at 11pm and through the night). On 28-Apr-2021, the patient experienced HYPERHIDROSIS (sweating). At the time of the report, HEADACHE (Little Headache), VACCINATION SITE PAIN (arm hurt), HYPERHIDROSIS (sweating) and PYREXIA (fever started at 11pm and through the night) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.      This case linked to MOD-2021-095147 (Patient Link).